Aether Biomedical, a medical robotics startup has raised an undisclosed amount in seed funding round led by Chiratae Ventures. The round also saw contribution from Joyance Partners and Sunfish Partners.

The firm announced that it will be utilizing the funds in commercialization of its product Zeus, a multi action bionic arm across the markets of India and Europe. Aether Biomedical will also continue its Research and Development efforts by creating the next generation of the bionic limb and building accessory products like prosthetic wrists and prosthetic elbows.

Aether Biomedical was founded by Dhruv Agarwal and Faith Jiwakhan in 2016 with the objective of developing rehabilitation devices based on biosignal processing. It claims that Zeus is a low-cost high efficacy product aimed to create data-driven rehabilitation accessible and more robust. Its state-of-the-art product is priced at a much affordable rate to bring a larger set of amputees under its purview.

There are reportedly over 10 million amputees globally out of which 80% reside in developing countries where the penetration of prosthesis is lesser than 10%, according to data stated by Aether. India and China are the fastest growing markets for prosthetics and orthotics in Asia Pacific region because of the increasing aging population, growing awareness about new technology and the availability of funds. The firm’s aim is to bridge this gap by introducing new age, scalable and insight driven solutions.

Dhruv Agrawal, Founder and CEO of Aether Biomedical stated, “Building at the intersection of robotics, mechatronics, research, insights, and innovation, we hope our solutions help 10 million+ amputees globally live better lives and re-invent medical tech.”

LEAVE A REPLY

Please enter your comment!
Please enter your name here